Poster on advfn suggests another outcome based on existing slate : New production dates : - Red Billabong went into production 3 weeks ago, - AWWTC will start production in October, - Phoenix will start production in October. Post production title to be packaged for AFM at the start of November : - Second Origin, - Anti Social. Completed film now selling : - Scopia : US festival this month. Aberdeen festival and then British Horror festival next month. According to a relaible filming web site, Starbright is currently casting.
Only the CEO now remains. Trading is suspended as the board is empty. Looks bleak, though talks are ongoing with backers.
22 Aug '14
...near to close yesterday ?
19 Aug '14
Something going down here.
19 May '14
19 May 2014 INTANDEM FILMS PLC ("Intandem" or the "Company") Issue of Equity & New Films Intandem Films plc (AIM: IFM, "Intandem" or the "Company"), the London based international film group, is pleased to announce a subscription for 50,133,331 ordinary shares (the "Subscription Shares") at a price of 0.375 pence per share (the "Placing"), raising gross cash proceeds of GBP175,000 together with settling GBP13,000 of outstanding director fees. The Subscription Shares will rank pari passu in all respects with the existing ordinary shares in the Company. The Company intends to utilise the net proceeds for general working capital purposes including attendance at the Cannes Film Festival and to settle certain current liabilities. The Company continues to operate at a net liabilities and a net current liabilities position, and with limited working capital for the foreseeable future. The Company is dependent on making commercial progress in the very near term or will require further new financing. Robert Mitchell, CEO and Andrew Brown and Billy Hurman, executive directors have subscribed in the Placing in lieu of outstanding director fees. In addition Chris Sykes, non executive director, has subscribed in the Placing for cash (subscription made by Katorox Limited which is controlled and wholly owned by Chris Sykes). Their participation and resultant interest is set out in the table below: Director Number of Subscription Total interest Percentage of enlarged Shares subscribed including Subscription share capital following Shares subscribed the Placing Robert Mitchell 2,133,333 2,133,333 0.5% Andrew Brown 266,667 5,196,667 1.1% Billy Hurman 533,333 3,723,333 0.8% Chris Sykes 533,333 533,333 0.1% Application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM and admission is expected to commence on 21 May 2014. Following the issue of equity, the enlarged issued share capital of the Company will comprise 458,801,978 ordinary shares of 0.1 pence each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. In addition, the Company has been appointed sales agent to 'The Greatest Englishman', 'Scopia' and 'Missing William'. Commenting on the Placing, Robert Mitchell, CEO of Intandem, said: "At the Cannes Film Festival we will be selling a number of films including the US biopic "REAGAN" for which we are anticipating a h
6 May '14
New film announced, yet to be financed: http://m.hollywoodreporter.com/entry/view/id/333417
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.